Search

everythinglearnresearchcommunity

for

Search:↓

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Both treatments for alopecia areata showed similar modest effectiveness.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Myc changes chromatin in stem cells, causing them to leave their niche.

Minoxidil can help regrow hair in alopecia areata patients.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Minoxidil and finasteride treat hair loss; more research needed for other options.

PRP more effective than minoxidil 5% for treating alopecia areata.

3% topical minoxidil effectively treats extensive alopecia areata with few side effects.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

A new drug delivery system using oil body-bound oleosin-rhFGF-10 improves wound healing and hair growth in mice.